Skip to main content
. Author manuscript; available in PMC: 2018 Jun 19.
Published in final edited form as: J Am Coll Cardiol. 2014 Apr 9;63(22):2388–2394. doi: 10.1016/j.jacc.2014.03.025

Table 1.

Characteristics of Patients at Initial ICD Implantation and at the Time of ICD Replacement

Initial Implantation (N = 231) Generator Replacement (N = 231) p Value
Age, yrs 65 ± 10 (66)   70 ± 9 (70) <0.01

White race       184 (80)         –   –

ICM       159 (69)         –   –
NICM         72 (31)         –   –

LVEF, %   23 ± 6 (25) 33 ± 14 (30) <0.01

CRT-D         86 (37)         –   –

Comorbidities
 Chronic kidney disease (stage III or greater)         51 (22)         68 (29) <0.01
 Hypertension       170 (74)       189 (82) <0.01
 Diabetes         99 (43)       107 (46) <0.01
 Atrial fibrillation         37 (16)         56 (24) <0.01
 History of stroke         33 (14)         37 (16)   0.13
 Dialysis dependent           1 (<1)           2 (1)   0.50
 Neoplastic disease           6 (3)         33 (14) <0.01
 Cognitive impairment           5 (2)           9 (4)   0.13
 Nursing facility resident           1 (<1)           2 (1)   0.50

Medication use
 ACE inhibitor or ARB       198 (86)       194 (84)   0.39
 Beta-blocker       177 (77)       200 (87) <0.01
 Antiarrhythmic drug         29 (13)         37 (16)   0.10

Values are mean ± SD (median) or n (%).

ACE = angiotensin-converting enzyme; ARB = angiotensin receptor blocker; CRT-D = cardiac resynchronization therapy with a defibrillator; ICD = implantable cardioverter-defibrillator; ICM = ischemic cardiomyopathy; LVEF = left ventricular ejection fraction; NICM = nonischemic cardiomyopathy.